RALLYBIO CORP's ticker is and the CUSIP is 75120L100. A total of 60 filers reported holding RALLYBIO CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,424,148 | -27.6% | 3,301,603 | 0.0% | 5.38% | +0.6% |
| Q1 2024 | $6,107,966 | -22.6% | 3,301,603 | 0.0% | 5.35% | -15.9% |
| Q4 2023 | $7,890,831 | -29.1% | 3,301,603 | 0.0% | 6.36% | -55.5% |
| Q3 2023 | $11,126,402 | -40.5% | 3,301,603 | 0.0% | 14.29% | -11.0% |
| Q2 2023 | $18,687,073 | -0.9% | 3,301,603 | 0.0% | 16.05% | +3.0% |
| Q1 2023 | $18,852,153 | -13.1% | 3,301,603 | 0.0% | 15.58% | -0.8% |
| Q4 2022 | $21,691,532 | -34.9% | 3,301,603 | +43.4% | 15.70% | -20.5% |
| Q3 2022 | $33,304,000 | +91.7% | 2,301,603 | 0.0% | 19.76% | +75.5% |
| Q2 2022 | $17,377,000 | +8.2% | 2,301,603 | 0.0% | 11.26% | +42.2% |
| Q1 2022 | $16,065,000 | -26.8% | 2,301,603 | 0.0% | 7.92% | -0.5% |
| Q4 2021 | $21,957,000 | -45.7% | 2,301,603 | 0.0% | 7.96% | -31.8% |
| Q3 2021 | $40,462,000 | – | 2,301,603 | – | 11.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,301,603 | $18,687,073 | 16.05% |
| Canaan Partners XI LLC | 2,059,712 | $11,657,970 | 8.26% |
| 5AM Venture Management, LLC | 3,630,724 | $20,549,898 | 5.12% |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,404,644 | $13,610,285 | 4.49% |
| Novo Holdings A/S | 2,187,999 | $12,384,074 | 0.96% |
| CHI Advisors LLC | 542,774 | $3,072,101 | 0.93% |
| Tekla Capital Management LLC | 1,727,067 | $9,775,199 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 375,960 | $2,127,934 | 0.36% |
| TPG GP A, LLC | 3,028,414 | $17,140,823 | 0.25% |
| VR Adviser, LLC | 268,532 | $1,519,891 | 0.24% |